Dr. Gonzalez-Martin on Rationale for Phase III PRIMA Trial in Advanced Ovarian Cancer OncLive 1:14 5 years ago 143 Далее Скачать
Dr. Gonzalez-Martin on the Impact of the PRIMA Trial in Advanced Ovarian Cancer OncLive 1:34 4 years ago 109 Далее Скачать
RECOURSE Trial: Phase III trial: The Onset of Neutropenia as a Treatment Response Indicator Oncology.TV 3:51 7 years ago 68 Далее Скачать
What everybody should know about Clinical Trials! - Part 6 - Phase 3 Trials GCP-Mindset - All About Clinical Research 4:02 4 years ago 3 345 Далее Скачать
Final Overall Survival Results From the Phase 3 SOLO2 Trial for Ovarian Cancer OncLive 25:59 4 years ago 1 069 Далее Скачать
Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel Approaches PeerView Oncology 57:11 2 years ago 5 710 Далее Скачать
Niraparib provides new hope for ovarian cancer patients Snappy Science 1:47 5 years ago 119 Далее Скачать
How to interpret clinical trial data – Examples from recent clinical trials European Society of Cardiology 37:30 6 years ago 46 607 Далее Скачать
Niraparib in newly diagnosed advanced ovarian cancer: PRIMA results VJOncology 4:34 5 years ago 945 Далее Скачать
PFS increase but no OS increase for niraparib in advanced ovarian cancer ecancer 6:02 3 months ago 149 Далее Скачать
The Phase 3 VALOR Trial: Adaptive Sample Size Re-estimation Cytel 8:35 11 years ago 2 154 Далее Скачать
PRIMA: Frontline Niraparib Maintenance Therapy in Ovarian Cancer OncLive 6:31 4 years ago 1 508 Далее Скачать
What everybody should know about Clinical Trials! - Part 7 - Phase 4 Trials GCP-Mindset - All About Clinical Research 2:55 4 years ago 4 960 Далее Скачать
Data Demonstrate Efficacy of 3 PARP Inhibitors in Ovarian Cancer Targeted Oncology 1:12 4 years ago 181 Далее Скачать
